Bivalirudin versus UFH with or without GP IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary PCI
30 August 2016 (11:36 - 11:54)
Organised by:
About the speaker

Department of Medical and Health Sciences Linkoping University, Linkoping (Sweden)
4 More presentations in this session


Doctor G. Giustino (New York, US)

Access the full session
The Event
ESC Congress 2016
30 August 2016
11:36 CET


